EXPERIMENTAL HIV / BREAST CANCER DRUG, leronlimab, shows promise in Coronavirus fight

[link to nypost.com (secure)]

The drug, leronlimab, is delivered by injection twice in the abdomen, the Daily Mail reported.

Of seven critically ill patients who received the drug in New York, two were removed from ventilators and two showed significant improvement.

Doctors right now don’t know quite how leronlimab works, but studies suggest it calms the overly aggressive immune response — known as a cytokine storm — that frequently leads to lung inflammation, pneumonia and potentially death.